Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Alejandro Rodriguez-Garcia, Alejandro Babayan-Sosa, Arturo Ramirez-Miranda, Concepcion Santa Cruz-Valdes, Everardo Hernandez-Quintela, Julio C Hernandez-Camarena, Nallely Ramos-Betancourt, Regina Velasco-Ramos & Raul E Ruiz-Lozano. (2022) A Practical Approach to Severity Classification and Treatment of Dry Eye Disease: A Proposal from the Mexican Dry Eye Disease Expert Panel. Clinical Ophthalmology 16, pages 1331-1355.
Read now
Read now
Philippe Daull, Stefano Barabino, Laurence Feraille, Karima Kessal, Mylene Docquier, Stephane Melik Parsadaniantz, Christophe Baudouin & Jean-Sébastien Garrigue. (2019) Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops. Current Eye Research 44:5, pages 476-485.
Read now
Read now
Saviana Gandolfo & Salvatore De Vita. (2019) Emerging drugs for primary Sjögren’s syndrome. Expert Opinion on Emerging Drugs 24:2, pages 121-132.
Read now
Read now
Agustin L Gonzalez. (2018) Safety and efficacy of lifitegrast 5% ophthalmic solution in contact lens discomfort. Clinical Ophthalmology 12, pages 2079-2085.
Read now
Read now
Ivonne V Lollett & Anat Galor. (2018) Dry eye syndrome: developments and lifitegrast in perspective. Clinical Ophthalmology 12, pages 125-139.
Read now
Read now
Javier Moreno-Montañés, Anne-Marie Bleau & Ana Isabel Jimenez. (2018) Tivanisiran, a novel siRNA for the treatment of dry eye disease. Expert Opinion on Investigational Drugs 27:4, pages 421-426.
Read now
Read now
Articles from other publishers (9)
Nandadeva Lokugamage, Imran H. Chowdhury, Ronald J. Biediger, Robert V. Market, Sayadeth Khounlo, Navin D. Warier, Shen-An Hwang, Jeffrey K. Actor, Darren G. Woodside, Upendra Marathi, Peter Vanderslice & Nisha Jain Garg. (2021) Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. npj Vaccines 6:1.
Crossref
Crossref
Khayam Naderi, Jack Gormley & David O’Brart. (2020) Cataract surgery and dry eye disease: A review. European Journal of Ophthalmology 30:5, pages 840-855.
Crossref
Crossref
Guruprasad R. Pattar, Gary Jerkins, David G. Evans, Gail L. Torkildsen, George W. Ousler, David A. Hollander, Mark Holdbrook & Michelle Senchyna. (2020) Symptom improvement in dry eye subjects following intranasal tear neurostimulation: Results of two studies utilizing a controlled adverse environment. The Ocular Surface 18:2, pages 249-257.
Crossref
Crossref
Amy Y. Tong, Samuel F. Passi & Preeya K. Gupta. (2020) Clinical Outcomes of Lifitegrast 5% Ophthalmic Solution in the Treatment of Dry Eye Disease. Eye & Contact Lens: Science & Clinical Practice 46:1, pages S20-S24.
Crossref
Crossref
Patricia J. McLaughlin, Joseph W. Sassani, Michelle B. Titunick & Ian S. Zagon. (2019) Efficacy and safety of a novel naltrexone treatment for dry eye in type 1 diabetes. BMC Ophthalmology 19:1.
Crossref
Crossref
Gianluca Baldanzi. 2001. eLS. eLS
1
19
.
H. Liang, K. Kessal, G. Rabut, P. Daull, J.S. Garrigue, S. Melik Parsadaniantz, M. Docquier, C. Baudouin & F. Brignole-Baudouin. (2019) Correlation of clinical symptoms and signs with conjunctival gene expression in primary Sjögren syndrome dry eye patients. The Ocular Surface 17:3, pages 516-525.
Crossref
Crossref
Darren G. Woodside & Peter Vanderslice. 2019. Translational Inflammation. Translational Inflammation
43
68
.
R J Buckley. (2018) Assessment and management of dry eye disease. Eye 32:2, pages 200-203.
Crossref
Crossref